New immune cell therapy tested for Tough-to-Treat cancers
NCT ID NCT06296056
Summary
This early-stage study tested the safety and initial effects of a new combination immune cell therapy for patients with advanced solid tumors that have spread and no longer respond to standard treatments. The trial involved 9 participants and aimed to find a safe dose and treatment schedule. Researchers measured side effects and looked for early signs that the therapy might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul Hospital
Ulaanbaatar, Mongolia
Conditions
Explore the condition pages connected to this study.